MedPoint Digital is proud to be recognized by Microsoft in a special report released on the Microsoft website, entitled “Software maker future-proofs products by developing in the cloud.” MedPoint has partnered with Microsoft to move its technology systems to Azure Platform-as-a-Service (PaaS), Microsoft’s most advanced cloud environment. Azure PaaS allows for more rapid innovation, better scalability, higher performance, and lower costs, ensuring MedPoint’s portal technology can continue to evolve with the biopharmaceutical industry. MedPoint has digitized key parts of the drug development and commercialization process, and Azure PaaS ensures that critical data, documents and resources are hosted in a highly secure, compliant environment. Using Azure PaaS, MedPoint’s newest technology, RegDoc eSafe™, will drive the ability of investigator sites to be truly paperless. To read the full report, click here.